PF-Atlas › Clinical Trials › NCT04901975
Fibrosis and the Fontan
Spironolactone · Phase 1
Registry ID
NCT04901975
Phase
Phase 1
Status
Completed
Drug / intervention
Spironolactone
Sponsor
Children's Hospital of Philadelphia
Start
2021-02-11
About this trial
Spironolactone is evaluated in NCT04901975, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Children's Hospital of Philadelphia. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT04901975 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.